AI 资本情报
Amgen Ventures · 机构档案
机构速览
Amgen 于 2004 年公告设立 Amgen Ventures，并将其描述为支持早期生物科技公司推进人类治疗方向发现的企业风险投资基金。此处记录的是设立时的定位，不代表当前基金规模或策略细节。
来源核验日期： · 依据 Amgen 2004 年设立公告，只表述基金成立时的方向；未外推其当前规模、团队或投资条款。
本库收录的融资关联
- BigHat Biosciences2026-09-24 · C轮 · 7500 万美元
关联仅表示收录记录中的参与，不代表完整投资组合或投资收益。
基本信息
| 公告所述基金类型 | 企业风险投资基金 来源 1 |
|---|---|
| 公告所述方向 | 早期生物科技公司及人类治疗 来源 1 |
发展节点
- 2004-11-11
Amgen 公告设立 Amgen Ventures。 来源 2
公开成绩与记录
- 融资来源记录：BigHat Biosciences · C轮 · 2026-09-24 · 本轮参投 · $75 million。这是本库收录的披露案例，不代表完整投资组合。 来源 3
原始来源
- 1. Amgen Announces the Formation of Amgen Ventures; Venture Capital Fund Designed to Provide Resources to Help Advance Early-Stage Biotechnology Companies and Human Therapeutics| Amgen
today announced the formation of Amgen Ventures, a corporate venture capital fund designed to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics.
- 2. Amgen Announces the Formation of Amgen Ventures; Venture Capital Fund Designed to Provide Resources to Help Advance Early-Stage Biotechnology Companies and Human Therapeutics| Amgen
Nov. 11, 2004--Amgen Inc. (NASDAQ:AMGN), the world's largest biotechnology company, today announced the formation of Amgen Ventures, a corporate venture capital fund designed to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics. Amgen Ventures reflects Amgen's commitment to helping patients through cutting-edge science and is an important component of Amgen's overall outreach strategy. Amgen Ventures can offer early stage companies access to Amge
- 3. BigHat Biosciences 宣布完成 7500 万美元 C 轮融资，以推进 AI 设计的治疗药物和领先的智能体数据平台，用于快速蛋白质设计
existing investors including 8VC, Alexandria Venture Investments, Amgen Ventures, Andreessen Horowitz (a16z), Discovery Ventures, GRIDS Capital, Intermountain Ventures, Eli Lilly and Company, Merck Global Health Innovation Fund, Quadrille Capital, and Section 32.